Background: Appendectomy decreases the risk of developing ulcerative colitis [UC], and is suggested to have a beneficial effect on the clinical course of established UC. However, recent studies showed no significantly decreased colectomy rate, and moreover an apparently increased risk of colorectal cancer [CRC]. We aimed to investigate the suggested correlation in a meta-analysis and to analyse possible confounding factors. Methods: A systematic review and meta-analysis were performed using MEDLINE, EMBASE, and the Cochrane Library. Data from studies describing the influence of appendectomy on colectomy and CRC were extracted from published reports. Exclusion criteria were patients aged <18 years, non-UC, and animal studies. Results: From 891 studies, 13 studies evaluating 73 323 UC patients [appendectomy n = 2859] were included. All studies, except one, were rated as poor quality. Overall, colectomy rate in appendectomised and non-appendectomised patients was not significantly different (odds ratio [OR] 1.25, 95% confidence interval [CI] 0.88-1.77, I 2 = 53%). The proportion of colectomies undertaken for CRC or high-grade dysplasia [HGD] was significantly higher after appendectomy [OR 2.85, 95% CI 1.40-5.78, I 2 = 32%], with 50% of the colectomies indicated for CRC/HGD compared with 9.4% in non-appendectomised patients. Possible additional confounding factors were a longer UC disease duration, less medication use, and a higher prevalence of primary sclerosing cholangitis [PSC] in appendectomised patients. Conclusions: Appendectomy in established UC is associated with apparently higher rates of subsequent CRC/HGD, but this appears to be due to inequalities in at-risk exposure between groups, presumably secondary to positive clinical effects of appendectomy on disease symptoms. This finding emphasises the importance of regular endoscopic surveillance in this patient group.
Introduction
An appendectomy is a protective factor against the development of ulcerative colitis [UC] , and is also suggested to confer beneficial effects on the clinical course of established disease. 1 As early as in 1987, Gilat et al. 2 evaluated childhood factors associated with inflammatory bowel disease, and reported an inverse relationship between appendectomy and subsequent diagnosis of UC. This observation was regarded as an incidental finding for many years, until another study found an appendectomy prevalence of 0.6% in UC patients compared with 25.4% in controls. 3 Thereafter, more epidemiological and case-control studies reported similar results, and led to an increase in interest over the last decade in the potential therapeutic benefits of an appendectomy in established UC. Various studies exploring this intervention reported lower relapse rates and a decreased risk of colectomy, making this relatively cheap procedure an attractive treatment option for UC patients. 4 However, more recently published data show contradictory findings after appendectomy in UC patients, with an apparently increased colectomy rate, and moreover an increased risk of colorectal cancer [CRC] . The retrospective database analysis of Parian et al., 5 including 2714 UC patients, found a higher risk of colectomy in 48 patients who underwent appendectomy after UC diagnosis and concluded that an appendectomy should not be recommended as a therapy for UC. Harnoy et al. 6 also reported an increased risk of CRC and highgrade dysplasia [HGD] in UC patients after appendectomy with an odds ratio of 16.88, although this study only included 15 patients undergoing appendectomy and the timing of appendectomy in relation to their UC diagnosis was unknown. If an appendectomy is indeed associated with an increased risk of the subsequent development of CRC, this would have considerable implications for ongoing clinical studies and daily clinical practice.
We systematically reviewed the literature and performed a meta-analysis to investigate if an appendectomy is associated with an increased risk of colectomy and of CRC/HGD in UC patients. Additionally, possible confounding factors for the development of CRC or HGD were evaluated, including disease duration, extent and severity of disease, primary sclerosing cholangitis [PSC] , and family history for CRC. 7 Our research questions were as follows.
[1] Is an appendectomy in UC patients associated with an increased risk of colectomy and CRC/HGD? [2] Is there a change in the colectomy indication after appendectomy? [3] What possible patient-level confounding factors should be taken into account when interpreting current data?
Methods

Search strategy and selection criteria
A systematic review and meta-analysis were performed according to the Preferred Reporting Items for Systematic Reviews and MetaAnalysis [PRISMA] guidelines. 8 All randomised controlled trials, cohort studies, case-control studies, and case series describing the influence of an appendectomy on the colectomy rate or risk of CRC or HGD in UC patients were included. Patients with any extent of the disease, and both active and non-active disease, were eligible. There were no limitations concerning timing of or reason for appendectomy, nor limitations concerning use of medication. Exclusion criteria were patient age <18 years, appendectomy performed in non-UC patients, and animal studies.
An electronic search was performed in MEDLINE [PubMed], EMBASE [Ovid] , and the Cochrane Library, with the last update on 10 July 2017. The search contained both MeSH and free text terms and was composed with a clinical librarian. Search terms used were 'ulcerative colitis' or 'colitis' or 'proctitis' or 'proctocolitis' or 'UC' or 'pancolitis' and 'appendectomy' or 'appendicectomy'. No restrictions considering the date or type of publication, language, or other methodological filters were used. Further details of the search are provided in Supplementary 1, Search strategy available as Supplementary data at ECCO-JCC online.
Two reviewers [MS and MK] independently screened the titles and abstracts of the studies obtained from the search. Cases of disagreement about inclusion were resolved by joint discussion and, when needed, the opinion of a third researcher [CB] was sought. The remaining articles were separately reviewed by reading the full-text version [by MS and MK]. The reference lists of relevant articles were cross-checked to find any additional studies of interest. Included articles were translated if they were not published in English or Dutch. We used data extracted from published reports, and contacted the study authors in cases where data were missing.
Data analysis
The co-primary outcomes of this study were colectomy rate and risk of CRC or HGD after appendectomy in UC patients. To investigate possible confounding factors for developing CRC or HGD, we specifically looked at UC duration, disease extent and severity, PSC, and family history of CRC. Patient characteristics and outcome data were obtained separately for appendectomised and non-appendectomised patients. The collected patient characteristics were: gender, age, age at UC diagnosis, age and timing of appendectomy, UC disease duration, extent and severity of disease [including symptoms, endoscopy results, and medication use], PSC, family history of CRC, and duration of follow-up. Outcome data contained: the percentage of colectomies including age at colectomy, the percentage of CRC and HGD and age at diagnosis, and the indication for colectomy.
Two investigators [MS and MK] independently assessed the risk of bias of the included studies according to the Newcastle Ottawa Quality Assessment Scale. 9 The quality items were adjusted for cohort studies and case-control studies. Studies with less than 5% loss to follow-up and a minimal follow-up duration of 8 years were considered acceptable since an increased CRC risk is only seen after a longer period of time. 10 The Newcastle Ottawa scale scores were rated following the Agency for Healthcare Research and Quality [AHRQ] standard as good, fair, or poor depending on the number of assigned stars.
11
A meta-analysis was performed comparing the risk of colectomy, and of CRC and/or HGD in appendectomised and non-appendectomised patients. The influence of timing of appendectomy, before or after the diagnosis of UC, was evaluated in subgroup analyses. A random-effects model was applied and an I 2 ≥60% was considered as a substantial heterogeneity. A p-value of <0.05 was statistically significant and the odds ratios and 95% confidence intervals [CIs] were reported. The statistical analyses were done using Review Manager [version 5.3].
Results
The systematic literature search resulted in 891 studies: 285 in PubMed, 592 in EMBASE, and 14 from the Cochrane Library. After removal of the duplicates, 573 records were screened on title and abstract. Main reasons for exclusion were: no patients with UC or appendectomy, no data about colectomy or CRC/HGD provided, and inappropriate study designs such as reviews and conference abstracts. In total, 81 full-text articles were assessed for eligibility. A further 13 articles were excluded because there was no full text available [most were old and therefore not retrievable], and 55 articles had different outcome parameters, including disease severity, hospitalisation, or requirement of medical therapy. Qualitative synthesis was done in 13 studies and, of these studies, 12 were eligible for the quantitative synthesis. More details can be obtained from Figure 1 .
There were two prospective cohort studies, 10 retrospective cohort studies, and one case-control study. Table 1 shows the study and patient characteristics of the included studies. A total of 73 323 UC patients were evaluated, of whom 2859 [3.9%] previously had an appendectomy. Patients who had an appendectomy were subdivided in three groups: appendectomy before UC diagnosis [n = 1879], appendectomy after UC diagnosis [n = 927], and appendectomy with timing unknown [n = 53]. Of the 13 included studies, two studies did not make a distinction between appendectomy before or after UC diagnosis. 6, 12 The follow-up ranged from a median of 14 months to 193 months; however, six studies did not report the follow-up time. All of the included studies, except one, were rated as poor quality studies. The retrospective study of Hallas et al. 13 was the only study meeting the criteria of a good quality study [Supplementary 
Appendectomy and the risk of colectomy
The risk of colectomy was investigated in 11 studies in 72 453 UC patients. Two studies observed a significantly higher colectomy risk in the appendectomy group, and two studies in the non-appendectomy group [ Table 2 ]. The prospective study of Bolin et al. 14 was not included in the final meta-analyses due to the lack of a control group.
The forest plot of the 10 resulting studies showed no significant difference in colectomy rate between the group with appendectomy and the group without appendectomy [OR 1.25, 95% CI 0.88-1.77, I 2 = 53%; Figure 
Appendectomy and the risk of CRC or HGD
A total of seven studies evaluated the risk of CRC or HGD in 5064 UC patients. Two studies 12, 15 reported cases of CRC including HGD; the other five studies 6, [16] [17] [18] [19] separated CRC from HGD [ Table 2 ]. Meta-analysis of the risk of having a colectomy for CRC or HGD showed a significant increase after appendectomy [OR 2.85, 95% CI 1.40-5.78, I 2 = 32%; Figure 3 ]. Subgroup analysis of the five studies looking at CRC risk specifically also showed a significant increase after appendectomy with an OR of 3. 
Confounding factors
The indication for colectomy was described in four of the studies, and the pooled weighted percentage of colectomies indicated for [therapy refractory] UC was 40.9% in appendectomised patient versus 86.3% in non-appendectomised patients. In appendectomised patients, 50% of the colectomies were performed for an indication of CRC or HGD, compared with 9.4% in non-appendectomised patients. When looking at the patient and disease characteristics, there are some possible confounding factors that might influence the risk of developing CRC or HGD in our included studies. UC disease duration was significantly increased in the appendectomy group in four of seven studies 5, 6, 16, 20 [ Table 3 ]. Furthermore, the average weighted disease duration across the included studies was 133.0 months in the appendectomy group versus 112.3 months in the non-appendectomy group. Also the age at colectomy was significantly higher in the appendectomy group compared with the non-appendectomy group in one out of three studies [median 49.0 versus 38.5 years, respectively][ Table 2 ]. This same study 6 also reported the age at colectomy for patients with CRC specifically, and the median age was 3 years older in the appendectomy group [44 versus 41 years], but this difference was not statistically significant. None of the studies reported the exact age at diagnosis of CRC or HGD in appendectomised and non-appendectomised patients separately.
As time to colectomy is related to disease severity, we also scored clinical symptoms, endoscopic severity, and need for medication. Unfortunately, symptoms and endoscopic severity were only reported in the uncontrolled study of Bolin et al. 14 Medication use was presented in seven studies, with a lower pooled weighted percentage of immunomodulators and/or biologics in the appendectomy group [18.0% versus 28.5%].
When looking at other well-known predictors for the development of CRC, we found a significantly higher percentage of patients with PSC in the appendectomy group in three out of seven studies, with a pooled weighted percentage of 12.1% versus 3.9% in the nonappendectomy group. Interestingly, the incidence tended to be higher in patients undergoing appendectomy before UC diagnosis [13. 8%] compared with after diagnosis [6.8%]. In contrast, there was no significant difference in extent of disease across studies, with extensive colitis in 44.5% of appendectomised patients versus 43.0% in the non-appendectomised patients. One study 17 looked at the extent of disease in CRC patients separately, and in this study all patients had extensive colitis irrespective of a previous appendectomy or not. Another study 6 described the location of CRC and, interestingly, this was more often in the right hemicolon in appendectomised patients compared with non-appendectomised patients [p = 0.004]. Finally, no difference in a positive family history for sporadic colorectal neoplastic changes was found between the appendectomy and non-appendectomy groups, although this was only reported in two studies. 6, 19 
Discussion
We have identified that the previously reported higher rates of CRC and/or HGD after appendectomy in established UC persist in metaanalysis, but are likely to be a result of a marked change in indication for colectomy, alongside unequal risk exposure due to delayed colectomy in those undergoing appendectomy. Significantly less colectomy operations were performed for colitis symptoms in the appendectomy group [ produces the aberrant impression of higher rates of malignant transformation in the appendectomy group-when in fact there are just less operations being performed for colitis. This must be interpreted alongside other positive findings which suggest a clinical benefit from appendectomy in terms of both decreasing relapse rates and postponing colectomy. We demonstrated a significantly longer duration of UC in the appendectomy group in four out of seven studies, accompanied by a decreased use of immunomodulators and/or biologics. If an appendectomy results in decreased disease activity but does not lead to mucosal healing, this might result in a situation where the need for colectomy can be postponed or avoided on the grounds of clinical symptoms. However, leaving a [subclinical] inflammatory colon in situ might promote tumour development, as the production of chemokines and cytokines facilitates tumour growth, genomic instability, and angiogenesis. 21 Therefore, a postponed colectomy might produce an apparently increased CRC risk over the long term, due to a disparity in at-risk exposure for appendectomised patients compared with the general UC population.
This hypothesis is further supported by results of the only two prospective series so far describing clinical results in therapyrefractory UC patients undergoing appendectomy. The study of Bolin et al. 14 showed an improvement in the clinical activity index score in 27/30 [90%] patients, but after 1 year only 12 [40%] patients had a complete resolution of symptoms. There was no description of the number of patients in endoscopic remission in this study. The long-term results of 28 patients reported in the abstract of another prospective cohort series showed clinical response in 13 [46%] patients and endoscopic remission in at least six [21%] patients median 4 years after appendectomy for therapy refractory UC. 22 Although the results were considered to be promising as this patient group was originally referred for colectomy, it also demonstrates that only a minority of patients achieve complete remission. These studies do suggest that an appendectomy can result in a beneficial clinical effect; a substantial proportion of patients appear to experience a reduction in inflammation and disease activity, thereby waiving the need for colectomy. In contrast, in our study we found no overall significant decrease in the risk of colectomy in appendectomised patients, although we identified a shift in the indication for colectomy from [therapy-refractory] disease activity to [pre]malignant degeneration. In the study of Harnoy et al., 6 the prevalence of CRC in appendectomised UC patients was 33%, whereas the overall prevalence of CRC in any UC patient is estimated to be around 4%. 23 The shift in indication might, over time, result in comparable colectomy rates in both groups.
Another well-known risk factor which is associated with the development of CRC in UC patients is PSC. The prevalence of PSC was significantly higher in the appendectomy group in three out of seven studies. The relation between appendectomy and the development of PSC has been analysed previously in several studies, and a recently published meta-analysis found a significant association with an OR of 1.37. 24 However, this meta-analysis included both PSC [without UC] and PSC-UC patients, and perhaps only the UC patients are at risk after appendectomy due to a distinct IBD phenotype with more frequent involvement of the right hemicolon. 25 In addition to this, the only study in our meta-analysis describing the location of CRC found significantly more cancers located in the right hemicolon in appendectomised patients. A Swiss nationwide cohort study including 2744 patients [which was not included in the aforementioned meta-analysis] builds upon this hypothesis, as the authors indicated an appendectomy as independent risk factor for developing PSC in UC patients [OR 4.11, p = 0.019]. 26 Further research is required to investigate this possible association and possible underlying immunological mechanisms.
Unfortunately, we cannot comment on other important risk factors for CRC like severity and a history of CRC in the family. 7 Due to the retrospective character of most of the included studies in this systematic review, data on these variables were often lacking.
There are several limitations to this study. As only two prospective studies could be included, the conclusions of our meta-analysis Cosnes et al. 14 are mainly based on retrospective data with its inherent shortcomings. Pooling data of these different study designs is generally not preferred, as this poses substantial heterogeneity. Even though the heterogeneity in our main analyses was low, it should be kept in mind that this might be due to simplification of the analytical model [from adjusted regression to non-adjusted regression]. Also, several studies did not present all relevant outcome parameters, which could lead to bias. An attempt was made to collect these data from the original author groups, but this was not completely successful. Lastly, it is difficult to clearly extrapolate these findings to clinical practice because, in the majority of the studies describing appendectomy and the risk of CRC/HGD, the appendectomy was performed before the diagnosis of UC. This impacts on the relevance to current UC sufferers. Compounding this, since we know that appendectomy protects against the development of UC in the first place, if a patient goes on to develop the condition having already had an appendectomy, this may perhaps be viewed as a special high-risk subset of a particularly virulent version of UC-hence the higher subsequent risk of CRC/ HGD. If an appendectomy performed after the diagnosis of UC postpones colectomy, when do we call this clinically relevant? Obviously, if this difference is 10 years, like the data presented by Harnoy et al., 6 an appendectomy will be interesting for this generally young patient group [e.g. with respect to fertility], but in our pooled data [including appendectomies both before and after the UC diagnosis] the difference was less compelling [112.3 versus 133.0 months]. The clinical relevance of postponing colectomy is dependent on the years gained with colon in situ and good quality of life. Unfortunately, it is impossible to comment on this with these retrospective data. A recently published abstract of prospective data demonstrated that quality of life measured by the disease-specific Inflammatory Bowel Disease Questionnaire [IBDQ] significantly improve after appendectomy, but it should be emphasised that this is a therapy-refractory patient group who were referred for colectomy. 22 In conclusion, this systematic review and meta-analysis show that when the data are pooled from previously published reports, the apparently significantly increased risk of CRC and HGD after appendectomy in UC patients persists. The increased risk of CRC and HGD is likely to be secondary to the fact that the colon is longer in situ because of the suggested positive effect of appendectomy on disease severity. With the current findings, discontinuation of ongoing studies on appendectomy in UC is not recommended. Conversely, we feel that this review confirms the clinical interest in the role of an appendectomy as therapy for UC. However, it is clear that there remains an ongoing risk of CRC or HGD in patients who may have clinically improved after appendectomy and, as such, this study emphasises the importance of ongoing regular endoscopic surveillance in appendectomised UC patients. Future studies should aim to address possible confounding factors when analysing the effect of an appendectomy on UC-and CRC-related outcomes.
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